| scholarly article | Q13442814 |
| P2093 | author name string | Isabelle Bedrosian | |
| George J Chang | |||
| Chung-Yuan Hu | |||
| P2860 | cites work | Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment | Q23922894 |
| Limits of observational data in determining outcomes from cancer therapy | Q31153256 | ||
| Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation | Q34084471 | ||
| Efficacy of prophylactic mastectomy in women with unilateral breast cancer: a cancer research network project | Q36082407 | ||
| Outcomes of breast-conservation therapy for invasive lobular carcinoma are equivalent to those for invasive ductal carcinoma | Q36595448 | ||
| Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers | Q36615112 | ||
| NCCN Practice Guidelines for Breast Cancer. | Q40725293 | ||
| A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors | Q41242105 | ||
| Age at first primary as a determinant of the incidence of bilateral breast cancer. Cumulative and relative risks in a population-based case-control study | Q43591628 | ||
| BILATERAL PRIMARY BREAST CANCER; A PROSPECTIVE CLINICOPATHOLOGICAL STUDY. | Q45006833 | ||
| Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial | Q46847543 | ||
| Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group | Q47189470 | ||
| Regression models for relative survival | Q47296894 | ||
| Role of detection method in predicting breast cancer survival: analysis of randomized screening trials. | Q51966307 | ||
| Efficacy of Bilateral Prophylactic Mastectomy in Women with a Family History of Breast Cancer | Q54089896 | ||
| Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population-based study | Q73580673 | ||
| Efficacy of contralateral prophylactic mastectomy in women with a personal and family history of breast cancer | Q74575349 | ||
| Prophylactic mastectomy in women with a high risk of breast cancer | Q77873695 | ||
| Update: NCCN practice guidelines for the treatment of breast cancer. National Comprehensive Cancer Network | Q77888377 | ||
| The relative survival rate: a statistical methodology | Q79381486 | ||
| [Statistical distribution of involved axillary lymph nodes in breast cancer] | Q81318243 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | breast cancer | Q128581 |
| P304 | page(s) | 401-409 | |
| P577 | publication date | 2010-02-25 | |
| P1433 | published in | Journal of the National Cancer Institute | Q400279 |
| P1476 | title | Population-based study of contralateral prophylactic mastectomy and survival outcomes of breast cancer patients | |
| P478 | volume | 102 |
| Q36972952 | Application of immediate breast reconstruction with silicon prosthetic implantation following bilateral mammary gland excision in treatment of young patients with early breast cancer |
| Q36339415 | Association between contralateral prophylactic mastectomy and breast cancer outcomes by hormone receptor status |
| Q47117572 | Association between unilateral or bilateral mastectomy and breast cancer death in patients with unilateral ductal carcinoma |
| Q40848631 | Benefits and risks of contralateral prophylactic mastectomy in women undergoing treatment for sporadic unilateral breast cancer: a decision analysis. |
| Q36734744 | Bilateral Mastectomy for Unilateral Breast Cancer: a Perplexing Trend |
| Q54659755 | Bilateral breast cancer: analysis of incidence, outcome, survival and disease characteristics. |
| Q38184906 | Bilateral breast cancers |
| Q38913440 | Bilateral mastectomy and the retreat from breast-conserving surgery |
| Q91598316 | Breast Cancer Knowledge and Decisions Made for Contralateral Prophylactic Mastectomy: A Survey of Surgeons and Women in the General Population |
| Q34989073 | Breast cancer in young women |
| Q57133852 | Breast cancer in young women |
| Q34306522 | Breast cancer in young women: special considerations in multidisciplinary care |
| Q30671803 | Breast cancer treatment across health care systems: linking electronic medical records and state registry data to enable outcomes research |
| Q44244138 | Breast surgeons' perceptions and attitudes towards contralateral prophylactic mastectomy |
| Q35671323 | Co-modulation analysis of gene regulation in breast cancer reveals complex interplay between ESR1 and ERBB2 genes |
| Q38846562 | Contralateral Prophylactic Mastectomy for Women with T4 Locally Advanced Breast Cancer |
| Q92630618 | Contralateral Prophylactic Mastectomy in Women with Unilateral Breast Cancer Who Are Genetic Carriers, Have a Strong Family History or Are just Young at Presentation |
| Q37661126 | Contralateral Prophylactic Mastectomy is Associated with a Survival Advantage in High-Risk Women with a Personal History of Breast Cancer |
| Q36812287 | Contralateral Prophylactic Mastectomy: Challenging Considerations for the Surgeon |
| Q31118195 | Contralateral Prophylactic Mastectomy (CPM) Consensus Statement from the American Society of Breast Surgeons: Data on CPM Outcomes and Risks |
| Q46044304 | Contralateral mastectomy improves survival in women with BRCA1/2-associated breast cancer |
| Q39553244 | Contralateral prophylactic mastectomy |
| Q35192288 | Contralateral prophylactic mastectomy after unilateral breast cancer: a systematic review and meta-analysis |
| Q35850183 | Contralateral prophylactic mastectomy and its association with reduced mortality: evidence for selection bias |
| Q89797153 | Contralateral prophylactic mastectomy in breast cancer: what to discuss with patients |
| Q37387444 | Contralateral prophylactic mastectomy in women with breast cancer: trends, predictors, and areas for future research |
| Q60922300 | Contralateral prophylactic mastectomy in young women with breast cancer: a population-based analysis of predictive factors and clinical impact |
| Q39150355 | Contralateral prophylactic mastectomy provides no survival benefit in young women with estrogen receptor-negative breast cancer |
| Q24658472 | Contralateral prophylactic mastectomy rate stable at major Canadian breast cancer center |
| Q26744320 | Contralateral prophylactic mastectomy: current perspectives |
| Q54445587 | Contralateral risk reducing mastectomy in Non-BRCA-Mutated patients. |
| Q38110977 | Contralateral risk-reducing mastectomy in sporadic breast cancer |
| Q35066801 | Contralateral risk-reducing mastectomy: review of risk factors and risk-reducing strategies |
| Q48082941 | Cost-effectiveness of contralateral prophylactic mastectomy for prevention of contralateral breast cancer |
| Q35584662 | Current knowledge on contralateral prophylactic mastectomy among women with sporadic breast cancer |
| Q37720955 | Decision making for breast cancer prevention among women at elevated risk |
| Q26749389 | Decision-Making in the Surgical Treatment of Breast Cancer: Factors Influencing Women's Choices for Mastectomy and Breast Conserving Surgery |
| Q33767098 | Disparities in contralateral prophylactic mastectomy use among women with early-stage breast cancer |
| Q36983389 | Establishing a program for individuals at high risk for breast cancer |
| Q44539298 | Factors influencing surgical and adjuvant therapy in stage I breast cancer: a SEER 18 database analysis |
| Q64242159 | Genetic ablation of mammary ducts through foxa1 prevents breast cancer occurrence |
| Q35899068 | HER-2 pulsed dendritic cell vaccine can eliminate HER-2 expression and impact ductal carcinoma in situ. |
| Q36973006 | Immediate reconstruction following nipple-sparing mastectomy: one option for young breast cancer patients with early stage disease |
| Q30838002 | Impact of availability of immediate breast reconstruction on bilateral mastectomy rates for breast cancer across the United States: data from the nationwide inpatient sample. |
| Q38206470 | Impact of breast reconstruction on the decision to undergo contralateral prophylactic mastectomy |
| Q35838312 | Impact of reconstruction and reoperation on long-term patient-reported satisfaction after contralateral prophylactic mastectomy |
| Q36943042 | Intentions for bilateral mastectomy among newly diagnosed breast cancer patients |
| Q91372196 | Magnitude of reduction in risk of second contralateral breast cancer with bilateral mastectomy in patients with breast cancer: Data from California, 1998 through 2015 |
| Q36026667 | Mastectomy and contralateral prophylactic mastectomy rates: an institutional review |
| Q43605887 | Operative risks associated with contralateral prophylactic mastectomy: a single institution experience |
| Q89390856 | Persistent Post-Mastectomy Pain: Risk Factors and Current Approaches to Treatment |
| Q92764191 | Predictors of uptake of contralateral prophylactic mastectomy in women with nonhereditary breast cancer |
| Q39091681 | Prognostic Factors for Metachronous Contralateral Breast Cancer: Implications for Management of the Contralateral Breast |
| Q43470540 | Prophylactic mastectomy of the contralateral breast |
| Q38223259 | Prophylactic mastectomy: who needs it, when and why. |
| Q37151892 | Prospective Study of Surgical Decision-making Processes for Contralateral Prophylactic Mastectomy in Women With Breast Cancer |
| Q34629071 | Rate of contralateral prophylactic mastectomy is influenced by preoperative MRI recommendations |
| Q43507790 | Re: Survival outcomes after contralateral prophylactic mastectomy: a decision analysis |
| Q30415050 | Risk of asynchronous contralateral breast cancer in noncarriers of BRCA1 and BRCA2 mutations with a family history of breast cancer: a report from the Women's Environmental Cancer and Radiation Epidemiology Study |
| Q52604887 | Risk-reducing mastectomy for the prevention of primary breast cancer. |
| Q35634061 | Role of preoperative magnetic resonance imaging in the surgical management of early-stage breast cancer |
| Q36400320 | SEOM clinical guidelines in early-stage breast cancer 2015 |
| Q37845314 | Selecting local therapy in the young breast cancer patient |
| Q39033804 | Society of Surgical Oncology Breast Disease Working Group Statement on Prophylactic (Risk-Reducing) Mastectomy |
| Q38738100 | State Variation in the Receipt of a Contralateral Prophylactic Mastectomy Among Women Who Received a Diagnosis of Invasive Unilateral Early-Stage Breast Cancer in the United States, 2004-2012. |
| Q40758851 | Surgeons' Perspectives of Contralateral Prophylactic Mastectomy |
| Q38967974 | Survival Outcomes and Pathologic Features Among Breast Cancer Patients Who Have Developed a Contralateral Breast Cancer |
| Q46442172 | Survival analysis of contralateral prophylactic mastectomy: a question of selection bias |
| Q51068059 | Survival outcomes after contralateral prophylactic mastectomy: a decision analysis. |
| Q40910371 | The Effect of Contralateral Prophylactic Mastectomy on Perioperative Complications in Women Undergoing Immediate Breast Reconstruction: A NSQIP Analysis. |
| Q26821902 | Unique features of young age breast cancer and its management |
| Q34436508 | Use of and mortality after bilateral mastectomy compared with other surgical treatments for breast cancer in California, 1998-2011. |
| Q48111239 | When is contralateral mastectomy warranted in unilateral breast cancer? |
| Q91055976 | Who should get a contralateral prophylactic mastectomy for breast cancer? |
Search more.